Subscribe for stories that matter!
Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George for Philadelphia Business Journal.
Under…
Before we send you to this site, please subscribe to our daily newsletter.
